You need to consider that regardless of how many patients have already been through when biopsy is done, 50% of the time it will come back node negative. Which means that the cancer has not spread to the lymph node. (Good for the patient, but bad for us as there won't be any cancer in the biopsy sample sent back to the States for Magsense imaging) This biopsy surgery ia what IBX is initially hoping to have people avoid in future and the resulting potential for Lymphedema where they no longer drain properly.
So mulriple could be say be up to 10 but ones that can be used to show the Magsense effectiveness as opposed to MRI might new still very low and therefore any early update would not be possible.
All in all good reports and updates on a terrible market day.
IBX Price at posting:
5.7¢ Sentiment: Hold Disclosure: Held
